Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating fecal flora alteration to eradicate carbapenemase-producing Enterobacteriaceae colonization is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Susy Hota | Conditions: Infection | Phase 2, Phase 3 | Status: SUSPENDED